Monday, November 16, 2026
7.9 C
London

FDA Rejects Summit Therapeutics’ Lung Cancer Drug Over Survival Data

The FDA has declined to approve a closely watched lung-cancer drug from Summit Therapeutics. Regulators issued a complete response letter to the company. The decision blocks the drug’s path to market for now.

The agency told Summit that the treatment must show it helps patients live longer. Current data did not meet that standard. The drug needs stronger evidence of a survival benefit.

Summit had positioned the therapy as a potential rival in a competitive lung-cancer market. Investors had tracked its progress closely. The rejection marks a significant setback.

The FDA’s decision focused on overall survival as the key measure. Earlier trial results had raised questions about durability. Regulators sought clearer proof of extended lifespan.

Summit said it will review the agency’s feedback and determine next steps. Additional studies may be required to support approval. The company has not set a timeline for new data.

The drug remains unapproved in the United States. Patients currently rely on other available treatments. Summit has not announced plans to seek approval elsewhere.

Analysts expect the company to reassess its development strategy. Further trials would add time and cost. The path forward depends on generating stronger survival evidence.

Hot this week

Trump Administration Moves to Close A.I. Chip Loophole Ahead of China Trip

The Trump administration is moving to close a loophole...

Trump Open to Jensen Huang Returning as Nvidia CEO Ahead of China Trip

President Trump said he would be open to Jensen...

Parents describe helping kids fight sports-betting addiction: ‘There’s no handbook’

Parents across the country are confronting a problem they...

My Husband Is Happily Retired at 64 and Thinks I Should Keep Working — Is That Fair?

A 64-year-old man has retired and believes his wife...

Nvidia Stock Falls Again as U.S. Tightens Rules on China’s Remote Access to AI Chips

Nvidia shares fell further after the U.S. Commerce Department...

Topics

Trump Administration Moves to Close A.I. Chip Loophole Ahead of China Trip

The Trump administration is moving to close a loophole...

Trump Open to Jensen Huang Returning as Nvidia CEO Ahead of China Trip

President Trump said he would be open to Jensen...

Parents describe helping kids fight sports-betting addiction: ‘There’s no handbook’

Parents across the country are confronting a problem they...

Nvidia Stock Falls Again as U.S. Tightens Rules on China’s Remote Access to AI Chips

Nvidia shares fell further after the U.S. Commerce Department...

EPA’s Chemical-Detecting Plane Fails to Deliver Real-Time Data as Toxic Emergencies Rise

The EPA’s chemical-detecting aircraft is flying fewer missions than...

Best Digital Photo Frames (2026): Aura, Skylight & Amazon Tested

Digital photo frames have multiplied in number and variety...
spot_img

Related Articles

Popular Categories

spot_imgspot_img